Davis Polk advised the representatives of the several underwriters in the offering. Adagio Therapeutics, Inc. executed the initial public offering of 20,930,000 shares of its common stock at...
Adagio Therapeutics’ $356 Million Initial Public Offering
Immuneering’s US$129.4 Million IPO
Sidley Austin advised the underwriters on the deal, while Choate and Latham & Watkins assisted Immuneering Corporation. Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a...
Xponential Fitness’ $120 Million Initial Public Offering
Davis Polk advised Xponential Fitness in its IPO, while Latham & Watkins represented the underwriters. Xponential Fitness, Inc. executed its $120 million initial public offering of 10,000,000...
Shoals Technologies Group’s $375 Million Stock Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in the offering. Shoals Technologies Group, Inc. and certain selling stockholders executed the $375 million SEC-registered offering...
Clarios International’s Initial Pubic Offering
Cleary Gottlieb represented the underwriters, led by BofA Securities and J.P. Morgan, in the initial public offering. Clarios International Inc. (“Clarios”), a world leader in advanced...
IDEAYA Biosciences’ $92 Million Common Stock Offering
Latham & Watkins advised IDEAYA Biosciences, while Davis Polk advised the underwriters in the offering. IDEAYA Biosciences, Inc. executed its public offering of 5,333,333 shares of common...
Logistics Innovation Technologies’ $300 Million Initial Public Offering
Davis Polk advised Guggenheim Securities, LLC acting as the sole bookrunner in the transaction. Logistics Innovation Technologies Corp. executed its $300 million initial public offering of 34,089,611...
Logistics Innovation Technologies’ $300 Million Initial Public Offering
Davis Polk advised Guggenheim Securities, LLC acting as the sole bookrunner in the transaction. Logistics Innovation Technologies Corp. executed its $300 million initial public offering of 34,089,611...
Monte Rosa Therapeutics’ $222.3 Million Initial Public Offering
Latham & Watkins LLP represented the underwriters in the offering. Monte Rosa Therapeutics, Inc. executed its initial public offering of 11,700,000 shares of common stock at a...
Leslie’s Secondary Offering
Latham & Watkins LLP represented the underwriters in the offering. Leslie’s, Inc., the largest direct-to-consumer brand in the US pool and spa care industry, serving residential,...
Valneva SE’s $107.6 Million Global Offering
Goodwin Procter advised Goldman Sachs & Co. LLC and the other underwriters on the deal. Hogan Lovells and Cooley advised Valneva. Gide advised Goldman Sachs, Jefferies,...
Rain Therapeutics’ $125 Million Initial Public Offering
Latham & Watkins LLP represented the underwriters in the offering. Rain Therapeutics Inc. (Rain), a clinical-stage company developing precision oncology therapeutics, executed its initial public offering...